PatientsVille.com Logo

PatientsVille

Abraxane Side Effects

Common Abraxane Side Effects


The most commonly reported Abraxane side effects (click to view or check a box to report):

Nausea (76)
Death (65)
Neutropenia (61)
White Blood Cell Count Decreased (60)
Dehydration (59)
Vomiting (59)
Haemoglobin Decreased (50)
Febrile Neutropenia (49)
Neutrophil Count Decreased (46)
Dyspnoea (46)
Sepsis (44)
Neuropathy Peripheral (43)
Diarrhoea (43)
Pneumonia (41)
Asthenia (40)
Fatigue (40)
Disease Progression (36)
Pyrexia (35)
Anaemia (34)
Decreased Appetite (30)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Abraxane Side Effects Reported to FDA

The following Abraxane reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Abraxane on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pancreatic Carcinoma, Blood Bilirubin Increased
This is a report of a 72-year-old female patient (weight: NA) from NL, suffering from the following symptoms/conditions: pancreatic carcinoma, who was treated with Abraxane (dosage: NA, start time: Feb 02, 2014), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Pancreatic Carcinoma
  • Blood Bilirubin Increased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Abraxane treatment in female patients, resulting in pancreatic carcinoma side effect. The patient was hospitalized.

Renal Failure, Breast Cancer Metastatic, Malaise, Pyrexia, Oropharyngeal Pain, Pain In Extremity
This report suggests a potential Abraxane Renal Failure, Breast Cancer Metastatic, Malaise, Pyrexia, Oropharyngeal Pain, Pain In Extremity side effect(s) that can have serious consequences. A 42-year-old female patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: breast cancer metastatic and used Abraxane (dosage: 430 Milligram) starting Feb 08, 2014. Soon after starting Abraxane the patient began experiencing various side effects, including:
  • Renal Failure
  • Breast Cancer Metastatic
  • Malaise
  • Pyrexia
  • Oropharyngeal Pain
  • Pain In Extremity
Drugs used concurrently:
  • Sodium Chloride
  • Domperidone (30 Milligram)
  • Paloxi (250 Milligram)
  • Neulasta (6 Milligram)
The patient was hospitalized. Although Abraxane demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as renal failure, may still occur.

Tongue Haemorrhage, Device Dislocation, Disease Recurrence
This Tongue Haemorrhage, Device Dislocation, Disease Recurrence problem was reported by a health professional from US. A 60-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: head and neck cancer. On Feb 24, 2014 this consumer started treatment with Abraxane (dosage: NA). The following drugs were being taken at the same time:
  • Carboplatin
  • Acetylcysteine (mucomyst)
  • Albuterol
  • Albuterol-ipratropium (duoneb)
  • Baclofen (lioresal)
  • Dextrose Syringe
  • Docusate (colace)
  • Insulin Aspart (novolog) Injection
When commencing Abraxane, the patient experienced the following unwanted symptoms/side effects:
  • Tongue Haemorrhage
  • Device Dislocation
  • Disease Recurrence
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as tongue haemorrhage, may become evident only after a product is in use by the general population.

Dyspnoea, Flushing
This is a report of a 43-year-old male patient (weight: NA) from PL. The patient developed the following symptoms/conditions: neoplasm malignant and was treated with Abraxane (dosage: NA) starting Jan 31, 2014. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Dyspnoea
  • Flushing
The patient was hospitalized. This opens a possibility that Abraxane treatment could cause the above reactions, including dyspnoea, and some male subjects may be more susceptible.



A 59-year-old female patient (weight: NA) from US with the following symptoms/conditions: NA started Abraxane treatment (dosage: NA) on NS. Soon after starting Abraxane treatment, the subject experienced various side effects, including:
    Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Abraxane.

    Cerebral Ischaemia, Cerebellar Ischaemia, Visual Field Defect
    A 78-year-old male patient from DE (weight: NA) experienced symptoms, such as: pancreatic carcinoma,metastases to liver,coronary artery disease,hypertension,hyperlipidaemia and was treated with Abraxane(dosage: 220 Milligram). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
    • Cerebral Ischaemia
    • Cerebellar Ischaemia
    • Visual Field Defect
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Abraxane efficacy:
    • Gemzar
    • Ass (100 Dosage Forms)
    • Delix (10 Dosage Forms)
    • Inegy (1 Dosage Forms)
    • Metoprolol (95 Dosage Forms)
    • Hydrochlorothiazid (12.5 Dosage Forms)
    • Pantozol (40 Dosage Forms)
    The patient was hospitalized and became disabled.

    Dehydration, Clostridium Difficile Infection
    In this report, Abraxane was administered for the following condition: NA.A 60-year-old male consumer from US (weight: NA) started Abraxane treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Dehydration
    • Clostridium Difficile Infection
    A possible interaction with other drugs could have contributed to this reaction:
    • Acetaminophen (tylenol)
    • Lactobacillus Acidophilus (acidophilus Oral)
    • Lansoprazole (prevacid)
    • Metoclopramide Hcl (reglan)
    • Ondansetron (zofran)
    • Oxycodone Hcl/acetaminophen (percocet Oral)
    • Prochlorperazine (compazine)
    • Psyllium Seed (with Dextrose) (fiber Oral)
    The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Abraxane treatment could be related to the listed above side effect(s).

    Back Pain, Fatigue, Constipation
    This is a report of the following Abraxane side effect(s):
    • Back Pain
    • Fatigue
    • Constipation
    A 47-year-old female patient from IE (weight: NA) presented with the following condition: breast cancer metastatic and received a treatment with Abraxane (dosage: 150 Milligram/sq. Meter) starting: 201201.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Abraxane treatment could be associated with the listed above side effect(s).

    Hypokalaemia, Dehydration, Abdominal Pain
    This Abraxane report was submitted by a 69-year-old male consumer from US (weight: NA). The patient was diagnosed with: pancreatic carcinoma and Abraxane was administered (dosage: NA) starting: 2013. The consumer developed a set of symptoms:
    • Hypokalaemia
    • Dehydration
    • Abdominal Pain
    Other drugs used simultaneously:
    • Gemcitabine
    • Hydroxychloroquine
    • Omeprazole (10 Milligram)
    • Levemir (45 Units)
    • Ondansetron
    The patient was hospitalized.Those unexpected symptoms could be linked to a Abraxane treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.


    This is a report of a possible correlation between Abraxane use and the following symptoms/side effect(s):
      which could contribute to an assessment of Abraxane risk profile.A 68-year-old male consumer from US (weight: NA) was suffering from NA and was treated with Abraxane (dosage: NA) starting NS.Other concurrent medications: NA.

      Neutropenia, Deep Vein Thrombosis, Abdominal Pain, Vomiting, Neuropathy Peripheral, Nausea, Alopecia, Asthenia, Pancreatic Carcinoma Metastatic
      A 61-year-old male patient from ES (weight: NA) presented with the following symptoms: pancreatic carcinoma and after a treatment with Abraxane (dosage: 125 Milligram/sq. Meter) experienced the following side effect(s):
      • Neutropenia
      • Deep Vein Thrombosis
      • Abdominal Pain
      • Vomiting
      • Neuropathy Peripheral
      • Nausea
      • Alopecia
      • Asthenia
      • Pancreatic Carcinoma Metastatic
      The treatment was started on Dec 18, 2012. Abraxane was used in combination with the following drugs:
      • Capecitabine
      • Gemcitabine (1000 Milligram/sq. Meter)
      • Gemcitabine (1250 Milligram/sq. Meter)
      • Enalapril
      • Analgesics
      The patient was hospitalized.This report could alert potential Abraxane consumers.

      Tumour Haemorrhage, Pulmonary Embolism, Venous Thrombosis Limb, Pancreatic Carcinoma, Dyspnoea, Polyneuropathy, Thrombocytopenia
      In this report, a 47-year-old male patient from DE (weight: NA) was affected by a possible Abraxane side effect.The patient was diagnosed with pancreatic carcinoma metastatic. After a treatment with Abraxane (dosage: NA, start date: 201210), the patient experienced the following side effect(s):
      • Tumour Haemorrhage
      • Pulmonary Embolism
      • Venous Thrombosis Limb
      • Pancreatic Carcinoma
      • Dyspnoea
      • Polyneuropathy
      • Thrombocytopenia
      The following simultaneously used drugs could have led to this reaction:
      • Folfirinox
      The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Abraxane treatment.

      Large Intestinal Stenosis, Ovarian Cyst, Constipation, Abdominal Pain Upper, Breast Cancer
      This is a report of a 38-year-old female patient from DE (weight: NA), who used Abraxane (dosage: 120 Milligram) for a treatment of breast cancer. After starting a treatment on Oct 11, 2012, the patient experienced the following side effect(s):
      • Large Intestinal Stenosis
      • Ovarian Cyst
      • Constipation
      • Abdominal Pain Upper
      • Breast Cancer
      The following drugs could possibly have interacted with the Abraxane treatment NA.Taken together, these observations suggest that a Abraxane treatment could be related to side effect(s), such as Large Intestinal Stenosis, Ovarian Cyst, Constipation, Abdominal Pain Upper, Breast Cancer.

      Dyspnoea, Flushing, Back Pain
      This dyspnoea side effect was reported by a physician from PL. A 59-year-old female patient (weight:NA) experienced the following symptoms/conditions: ovarian cancer. The patient was prescribed Abraxane (dosage: 293 Milligram), which was started on Dec 30, 2013. Concurrently used drugs:
      • Carboplatin (544 Milligram)
      When starting to take Abraxane the consumer reported the following symptoms:
      • Dyspnoea
      • Flushing
      • Back Pain
      The patient was hospitalized. These side effects may potentially be related to Abraxane.

      Musculoskeletal Pain
      This is a Abraxane side effect report of a 68-year-old male patient (weight:NA) from JP, suffering from the following symptoms/conditions: gastric cancer,epilepsy,insomnia,vitamin supplementation, who was treated with Abraxane (dosage:148 Milligram, start time: Jun 13, 2013), combined with:
      • Tegretol (200 Milligram)
      • Benzalin (5 Milligram)
      • Vitamedin (2 Capsule)
      , and developed a serious reaction and a musculoskeletal pain side effect. The patient presented with:
      • Musculoskeletal Pain
      which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Abraxane treatment in male patients suffering from gastric cancer,epilepsy,insomnia,vitamin supplementation, resulting in musculoskeletal pain.

      Device Related Infection
      This report suggests a potential Abraxane device related infection side effect(s) that can have serious consequences. A 41-year-old female patient from DE (weight:NA) was diagnosed with the following health condition(s): breast cancer and used Abraxane (dosage: NA) starting Sep 27, 2013. Soon after starting Abraxane the patient began experiencing various side effects, including:
      • Device Related Infection
      Drugs used concurrently:
      • Trastuzumab (8 Milligram/kilogram)
      • Trastuzumab
      • Pertuzumab
      • Pertuzumab
      • Tilidin
      • Gabapentin (90 Milligram)
      • Enoxaparin Sodium
      • Amoxicillin Trihydrate/clavulanate Potassium (875/125)
      The patient was hospitalized. Although Abraxane demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as device related infection, may still occur.

      Epistaxis, Myocardial Infarction
      This epistaxis problem was reported by a physician from BE. A 68-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): breast cancer metastatic,hypertension.On Jan 06, 2013 a consumer started treatment with Abraxane (dosage: NA). The following drugs/medications were being taken at the same time:
      • Tildiem (200 Milligram)
      • Coversyl (5 Milligram)
      • Duovent
      • Pulmicort
      • Seretid
      • Daflon (600 Milligram)
      When commencing Abraxane, the patient experienced the following unwanted symptoms /side effects:
      • Epistaxis
      • Myocardial Infarction
      Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as epistaxis, may become evident only after a product is in use by the general population.

      Pneumonia, Respiratory Failure
      This is a Abraxane side effect report of a 67-year-old male patient (weight: NA) from US. The patient developed the following symptoms/conditions: head and neck cancer and was treated with Abraxane (dosage: NA) starting NS. Concurrently used drugs:
      • Benefiber (nutrisource Fiber)
      • Celecoxib (celebrex)
      • Nexium
      • Guaifenesin (robitussin)
      • Hydrocodone-acetaminophen (lortab Lactose-free Food/fiber (isosource 1.5 Cal Orp.l)
      • Multivitamin/iron/folic Acid (multi Complete With Iron Oral)
      • Naproxen Sodium (aleve Oral)
      • Pseudoephedrine (sudafed)
      Soon after that, the consumer experienced the following of symptoms:
      • Pneumonia
      • Respiratory Failure
      This opens a possibility that Abraxane could cause pneumonia and that some male patients may be more susceptible.


      A 63-year-old male patient (weight: NA) from US with the following symptoms: pancreatic carcinoma started Abraxane treatment (dosage: NA) on NS. Soon after starting Abraxane treatment, the consumer experienced several side effects, including:
        . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Abraxane side effects, such as death.

        Alveolitis Allergic, Cholecystitis
        This alveolitis allergic side effect was reported by a physician from NL. A 65-year-old male patient (weight:NA) experienced the following symptoms/conditions: pancreatic carcinoma metastatic.The patient was prescribed Abraxane (dosage: 125 Milligram/sq. Meter), which was started on Jan 08, 2014. Concurrently used drugs: NA..When starting to take Abraxane the consumer reported symptoms, such as:
        • Alveolitis Allergic
        • Cholecystitis
        These side effects may potentially be related to Abraxane. The patient was hospitalized.

        Multi-organ Failure
        This is a report of a 56-year-old female patient (weight: NA) from IE, suffering from the following symptoms/conditions: breast cancer metastatic, who was treated with Abraxane (dosage: 264 Milligram, start time: Aug 30, 2013), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
        • Multi-organ Failure
        which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Abraxane treatment in female patients, resulting in multi-organ failure side effect.


        This report suggests a potential Abraxane side effect(s) that can have serious consequences. A 71-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Abraxane (dosage: NA) starting NS. Soon after starting Abraxane the patient began experiencing various side effects, including:
          Drugs used concurrently: NA. Although Abraxane demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as death, may still occur.

          Lung Cancer Metastatic
          This Lung Cancer Metastatic problem was reported by a health professional from US. A 59-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: lung cancer metastatic. On May 13, 2013 this consumer started treatment with Abraxane (dosage: 100 Milligram/sq. Meter). The following drugs were being taken at the same time: NA. When commencing Abraxane, the patient experienced the following unwanted symptoms/side effects:
          • Lung Cancer Metastatic
          Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as lung cancer metastatic, may become evident only after a product is in use by the general population.

          Pancytopenia, Jaundice
          This is a report of a 41-year-old male patient (weight: NA) from FR. The patient developed the following symptoms/conditions: pancreatic carcinoma,metastases to liver and was treated with Abraxane (dosage: NA) starting Sep 25, 2013. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
          • Pancytopenia
          • Jaundice
          The patient was hospitalized. This opens a possibility that Abraxane treatment could cause the above reactions, including pancytopenia, and some male subjects may be more susceptible.

          Haematuria, Febrile Neutropenia, Anaemia
          A 62-year-old patient (weight: NA) from DE with the following symptoms/conditions: breast cancer metastatic started Abraxane treatment (dosage: NA) on Aug 16, 2013. Soon after starting Abraxane treatment, the subject experienced various side effects, including:
          • Haematuria
          • Febrile Neutropenia
          • Anaemia
          Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients could be more vulnerable to Abraxane.

          1 of 42 



          Top 10 Abraxane Side Effects for Men

          Men Side EffectsReports
          Dehydration 24
          Death 22
          Febrile Neutropenia 19
          Haemoglobin Decreased 15
          Neutropenia 14
          Pancreatic Carcinoma 14
          Vomiting 14
          Nausea 13
          Pneumonia 13
          Diarrhoea 12

          Keep Track of Side Effects

          Note Your Observations

          It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

          Why Your Notes are Important

          Your notes could be helpful in several ways:

        • You can use them to remind you of details that may alert your health care professional(s) to a problem
        • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

        • Log Form

          You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

          Medicine Name and Dosage:
          Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
          Scale: 1 = very mild to 10 = very bad

          You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


          Discuss Abraxane Side Effects

          Did You Have a Abraxane Side Effect?

          Yes, Severe
          Yes, Moderate
          Yes, Minor
          No

          How Effective is Abraxane for You?

          Exceeded Expectations
          Effective
          Somewhat Effective
          Not Effective

          Abraxane Safety Alerts, Active Ingredients, Usage Information

          Abraxane Dosage, Warnings, Usage.

          Side Effects reported to FDA: 1026

          Abraxane safety alerts: No

          Reported deaths: 294

          Reported hospitalizations: 560

          Latest Abraxane clinical trials

          Abraxane Reviews

          No reviews, be a first to report a side effect via side effect reporting form